1. Home
  2. TW vs DXCM Comparison

TW vs DXCM Comparison

Compare TW & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TW
  • DXCM
  • Stock Information
  • Founded
  • TW 1996
  • DXCM 1999
  • Country
  • TW United States
  • DXCM United States
  • Employees
  • TW N/A
  • DXCM N/A
  • Industry
  • TW Investment Bankers/Brokers/Service
  • DXCM Medical/Dental Instruments
  • Sector
  • TW Finance
  • DXCM Health Care
  • Exchange
  • TW Nasdaq
  • DXCM Nasdaq
  • Market Cap
  • TW 27.5B
  • DXCM 28.0B
  • IPO Year
  • TW 2019
  • DXCM 2005
  • Fundamental
  • Price
  • TW $132.45
  • DXCM $74.52
  • Analyst Decision
  • TW Strong Buy
  • DXCM Buy
  • Analyst Count
  • TW 15
  • DXCM 17
  • Target Price
  • TW $131.64
  • DXCM $101.29
  • AVG Volume (30 Days)
  • TW 851.4K
  • DXCM 4.9M
  • Earning Date
  • TW 10-30-2024
  • DXCM 10-24-2024
  • Dividend Yield
  • TW 0.30%
  • DXCM N/A
  • EPS Growth
  • TW 21.01
  • DXCM 83.21
  • EPS
  • TW 2.08
  • DXCM 1.67
  • Revenue
  • TW $1,630,279,000.00
  • DXCM $3,954,000,000.00
  • Revenue This Year
  • TW $33.54
  • DXCM $13.10
  • Revenue Next Year
  • TW $16.06
  • DXCM $14.82
  • P/E Ratio
  • TW $64.88
  • DXCM $45.12
  • Revenue Growth
  • TW 29.40
  • DXCM 16.19
  • 52 Week Low
  • TW $86.06
  • DXCM $62.34
  • 52 Week High
  • TW $137.44
  • DXCM $142.00
  • Technical
  • Relative Strength Index (RSI)
  • TW 62.05
  • DXCM 58.10
  • Support Level
  • TW $127.03
  • DXCM $72.94
  • Resistance Level
  • TW $137.44
  • DXCM $78.16
  • Average True Range (ATR)
  • TW 3.14
  • DXCM 2.45
  • MACD
  • TW 0.44
  • DXCM 0.40
  • Stochastic Oscillator
  • TW 74.14
  • DXCM 66.71

About TW Tradeweb Markets Inc.

Founded in 1998 and headquartered in New York City, Tradeweb Markets is a leading fixed-income trading platform. While it does offer electronic processing for some voice-negotiated trades, the company focuses primarily on providing electronic trading networks that connect broker/dealers, institutional clients, and retail customers. While the company offers trading in a wide variety of products, the bulk of its business is in U.S. and European government debt, mortgage-backed securities, interest-rate swaps, and U.S. and international corporate bonds. The firm also sells fixed-income trading and price data, primarily through a deal with Refinitiv's Eikon service.

About DXCM DexCom Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

Share on Social Networks: